Tufts Medicine’s management said in the report that last year’s first quarter operating loss was reduced by “two significant one-time items.” The system received $41 million in one-time grants from the state and the federal government, and $24 million in revenue from a 340B settlement. Excluding those two items, the system would have seen an operating loss of $71.5 million in the first quarter of 2024.
“Eliminating these one-time items from each fiscal year would show an improvement of $43 million,” management said in the report.
Tufts reported total operating revenue of $710.7 million in the three months ended Dec. 31, up from $701.5 million reported in the same period last year.
Operating expenses totaled $739.7 million in the first quarter of 2025, up from $707.9 million reported over the same period last year. Salaries, wages and benefits totaled $398.4 million in the first quarter compared to $392.8 million in the same quarter last year. Supplies and other expenses totaled $192.2 million, up from $178.6 million.
The system had long-term debt of $886.8 million as of Dec. 31.
Tufts Medicine reported a net loss of $26.6 million in the first quarter, down from a net income of $22 million in the same quarter last year.
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.